You are here:

Olmesartan medoxomil (Olmetec®)


Following a full submission.

Accepted for restricted use within NHS Scotland.

Olmesartan has been shown to be at least as effective as other angiotensin II receptor antagonists (AIIAs) for the treatment of hypertension. It may be considered for use, along with other A11As, as an alternative in patients unable to tolerate an ACE inhibitor.

Drug Details

Drug Name: Olmesartan medoxomil (Olmetec®)
SMC Drug ID: 78/03
Manufacturer: Sankyo Pharma UK Ltd
Indication: Hypertension
BNF Category:
Sub Category: 2.5 Hypertension and heart failure
Submission Type: Full submission
Status: Restricted
Date Advice Published: 10 November 2003